Abstract:Background Glioma is the most common malignant brain tumor in adults, with its tumor-promoting immune microenvironment always being intricate to handle with. Amounts of evidence has accumulated to suggest that alternative splicing (AS) is related to tumor immune microenvironment. However, comprehensive analysis of immune-related AS events and their clinical significance are still lacking in glioma. Methods AS events and transcriptome data of 653 glioma patients were downloaded online. ssGSEA was performed on transcriptome data of 653 patients to divided them into low, medium and high immune cell infiltration groups. Immune-related AS events were filtrated based on this grouping. Then lasso Cox regression analysis and multivariate Cox regression analysis were done to achieve an immune-related AS events prognostic signature for glioma. Kaplan-Meier analysis, ROC analyses, univariate Cox regression and multivariate Cox regression were performed to reveal the independent prognostic role of this signature. Meanwhile, a nomogram was constructed to achieved better prognostic value for glioma patients. Besides, functional enrichment analyses and correlation analyses with immune cells infiltration were used to validated the immune-related characteristic of this signature. Results 36 immune-related AS events were achieved based on the grouping mentioned above. A nine-immune-related alternative splicing event signature was built for glioma patients. This signature showed an independent prognostic value and a nomogram containing gender, age, Karnofsky performance score, grade, IDH status, MGMT promoter status and risk score derived from the signature was constructed with a higher predictive ability for overall survival. Association with the infiltration of immune cell subtypes was validated and functional enrichment analysis found that the signature was mainly enriched in immune-related and pro-tumor functions. Conclusion Our research presented all immune-related AS events in glioma, identified an immune-related prognostic AS events risk model and a nomogram was constructed to predict the prognosis individually and more precisely. Tight connection was verified between this signature and clinical characteristics. Also, immune cells infiltration and immune checkpoints expression level were proved to link to risk scores, which enhanced the understanding of relationship between AS events and glioma immune microenvironment, firstly revealing the potential role of AS in immunotherapy of glioma.

Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma

Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response

Switched alternative splicing events as attractive features in lung squamous cell carcinoma

Landscape of Alternative Splicing Events Related to Prognosis and Immune Infiltration in Glioma: A Data Analysis and Basic Verification

Alternative Splicing Events in Tumor Immune Infiltration in Renal Clear Cell Carcinomas

Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer

Clinical Significance of Prognostic Alternative Splicing Signature in Tumor Immune Environment and Immune Therapy of Hepatocellular Carcinoma

Comprehensive Characterization of Alternative Mrna Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling.

Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma

Comprehensive Analysis of Alternative Splicing Profiling Reveals Novel Events Associated with Prognosis and the Infiltration of Immune Cells in Prostate Cancer.

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma

Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma

Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis

Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-AdenocarcinomasResearch in Context

Identification of Immune Activation-Related Gene Signature for Predicting Prognosis and Immunotherapy Efficacy in Lung Adenocarcinoma

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma

A Novel Immune-Related Long Non-Coding RNAs Risk Model for Prognosis Assessment of Lung Adenocarcinoma.

Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data

Systematic Profiling of Alternative Splicing Events and Splicing Factors in Left- and Right-Sided Colon Cancer

Genome-wide identification of pan-cancer common and cancer-specific alternative splicing events in 9 types of cancer